Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)
China · Delayed Price · Currency is CNY 4.630
-0.110 (-2.32%)
Sep 10, 2026, 12:14 PM CST
SHE:002793 Revenue
Luoxin Pharmaceuticals Group Stock had revenue of 564.73M CNY in the quarter ending June 30, 2026, a decrease of -5.01%. This brings the company's revenue in the last twelve months to 2.34B, down -4.94% year-over-year. In the year 2025, Luoxin Pharmaceuticals Group Stock had annual revenue of 2.27B, down -14.12%.
Revenue (ttm)
2.34B
Revenue Growth
-4.94%
P/S Ratio
2.20
Revenue / Employee
791.25K
Employees
2,962
Market Cap
5.16B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.27B | -373.91M | -14.12% |
| Dec 31, 2024 | 2.65B | 283.50M | 11.99% |
| Dec 31, 2023 | 2.36B | -1.22B | -34.11% |
| Jan 1, 2023 | 3.59B | -2.89B | -44.62% |
| Jan 1, 2022 | 6.48B | 381.70M | 6.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Hunan Jiudian Pharmaceutical | 2.89B |
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 2.42B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.56B |
| Bide Pharmatech | 1.38B |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 1.33B |
| Beijing Beilu Pharmaceutical | 1.29B |
| Jiangsu Jibeier Pharmaceutical | 1.00B |
| ChengDu ShengNuo Biotec | 911.15M |